Synaptogenix Inc (SNPX)

[SF Wolf]

My opinion concerning the Shelf Registration announced Friday afternoon is that Neurotrope’s Management made the right decision.

If we get great data and the stock were to dramatically appreciate management would be remiss if there was no shelf in place. I would also agree with runncoach when he states “My personal opinion is the company won't sell shares before the results...”

There is very little time until the results will be announced.

Moreover, Neurotrope, once they receive the study results from their contract research organization (CRO), will likely proceed to thoroughly review the data and conduct their own statistical analysis to check for accuracy, prior to the study release. NTRP could very well have the data from their CRO in the next couple of weeks.

In that context I see the Shelf Registration as the company positioning itself for a positive study outcome and not an attempt to raise money prior to their data release.

On balance, it looks bullish to me, even if we have a choppy opening Monday morning.